⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18533018 | 0.61 | — | — | |
| SCHEMBL5576943 | 0.60 | — | — | |
| SCHEMBL1136777 | 0.53 | — | — | |
| SCHEMBL21819622 | 0.52 | SLC2A1 (0.36) | — | |
| Hydrochloric Acid SCHEMBL11511320 | 0.50 | SLC2A1 (0.39) | — | |
| SCHEMBL4964070 | 0.49 | NSD2 (0.43) | — | |
| SCHEMBL21819582 | 0.49 | NSD2 (0.43) | — | |
| Bromide SCHEMBL11511582 | 0.47 | NSD2 (0.42) | — | |
| SCHEMBL722291 | 0.46 | — | — | |
| Benzoquinone SCHEMBL9134802 | 0.46 | ALDH1A1 (0.80) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 243 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240226309-A1 | HEAD AND NECK CANCER COMBINATION THERAPY COMPRISING AN IL-2 CONJUGATE AND CETUXIMAB | Synthorx, Inc. (US) | 2024-07-11 | — | — | US | disclosed |
| WO-2024137864-A1 | CANCER THERAPY WITH IL-2 CONJUGATES AND CHIMERIC ANTIGEN RECEPTOR THERAPIES | Synthorx, Inc. (US) | 2024-06-27 | — | — | WO | disclosed |
| WO-2024136899-A1 | CANCER THERAPY WITH IL-2 CONJUGATES AND CHIMERIC ANTIGEN RECEPTOR THERAPIES | Synthorx, Inc. (US) | 2024-06-27 | — | — | WO | disclosed |
| US-20240117363-A1 | PRODUCTION OF UNNATURAL NUCLEOTIDES USING A CRISPR/CAS9 SYSTEM | THE SCRIPPS RESEARCH INSTITUTE | 2024-04-11 | — | — | US | disclosed |
| EP-4346903-A1 | HEAD AND NECK CANCER COMBINATION THERAPY COMPRISING AN IL-2 CONJUGATE AND PEMBROLIZUMAB | Synthorx, Inc. (US) | 2024-04-10 | — | — | EP | disclosed |
| EP-4346904-A1 | HEAD AND NECK CANCER COMBINATION THERAPY COMPRISING AN IL-2 CONJUGATE AND CETUXIMAB | Synthorx, Inc. (US) | 2024-04-10 | — | — | EP | disclosed |
| EP-4326239-A1 | EXTRACELLULAR VESICLES LOADED WITH BIOMOLECULES | Spot Biosystems Ltd. (US) | 2024-02-28 | — | — | EP | disclosed |
| US-11879145-B2 | Reagents and methods for replication, transcription, and translation in semi-synthetic organisms | THE SCRIPPS RESEARCH INSTITUTE (US) | 2024-01-23 | — | — | US | disclosed |
| US-20230416327-A1 | IMMUNO ONCOLOGY THERAPIES WITH IL-2 CONJUGATES | Synthorx, Inc. (US) | 2023-12-28 | — | — | US | disclosed |
| EP-4291243-A1 | LUNG CANCER COMBINATION THERAPY WITH IL-2 CONJUGATES AND AN ANTI-PD-1 ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF | Synthorx, Inc. (US) | 2023-12-20 | — | — | EP | disclosed |
| WO-2001012223-A2 | METHODS OF MODULATING AN IMMUNE RESPONSE USING IMMUNOSTIMULATORY SEQUENCES AND COMPOSITIONS FOR USE THEREIN | DYNAVAX TECHNOLOGIES CORPORATION (US) | 2001-02-22 | — | — | WO | disclosed |
| WO-2001002007-A1 | METHOD FOR ENHANCING AN IMMUNE RESPONSE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2001-01-11 | — | — | WO | disclosed |
| WO-2000054803-A2 | IMMUNOSTIMULATORY NUCLEIC ACIDS AND ANTIGENS | PANACEA PHARMACEUTICALS, LLC (US) | 2000-09-21 | — | — | WO | disclosed |
| WO-2000021556-A1 | ANTI HIV COMPOSITIONS COMPRISING IMMUNOSTIMULATORY POLYNUCLEOTIDES AND HIV ANTIGENS | DYNAVAX TECHNOLOGIES CORPORATION (US) | 2000-04-20 | — | — | WO | disclosed |
| EP-0986572-A2 | IMMUNOSTIMULATORY OLIGONUCLEOTIDES, COMPOSITIONS THEREOF AND METHODS OF USE THEREOF | Dynavax Technologies Corporation (US) | 2000-03-22 | — | — | EP | disclosed |
| WO-1999062923-A2 | IMMUNOSTIMULATORY OLIGONUCLEOTIDES WITH MODIFIED BASES AND METHODS OF USE THEREOF | DYNAVAX TECHNOLOGIES CORPORATION (US) | 1999-12-09 | — | — | WO | disclosed |
| EP-0930893-A1 | IMMUNOSTIMULATORY POLYNUCLEOTIDE/IMMUNOMODULATORY MOLECULE CONJUGATES | The Regents of The University of California (US) | 1999-07-28 | — | — | EP | disclosed |
| WO-1998055495-A2 | IMMUNOSTIMULATORY OLIGONUCLEOTIDES, COMPOSITIONS THEREOF AND METHODS OF USE THEREOF | DYNAVAX TECHNOLOGIES CORPORATION (US) | 1998-12-10 | — | — | WO | disclosed |
| WO-1998016247-A1 | IMMUNOSTIMULATORY POLYNUCLEOTIDE/IMMUNOMODULATORY MOLECULE CONJUGATES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1998-04-23 | — | — | WO | disclosed |
| CN-1078235-A | Medicinal compound | LILLY CO ELI (US) | 1993-11-10 | — | — | CN | disclosed |